Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Colin Hislop Insider Profile
4 Followers
Colin Hislop, CMO at Anthera Pharmaceuticals, holds 23.83K shares in Aravive (Ticker: ARAV), holds 21.04K shares in Anthera Pharmaceuticals (Ticker: ANTH). Most recently, Colin Hislop Sold ― shares of Aravive on Oct 23, 2017 for an estimated value of 1.70K.
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+62.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CMO
Roles that Colin Hislop holds in companies
Most Profitable Insider Trade
Stock:
Aravive
(ARAV)
(ARAV)
Rating:Informative Sell
Date:Oct 23, 2017 - Oct 23, 2018
Return:+63.00%
The most profitable trade made by Colin Hislop
Colin Hislop's Trading History
Anthera Pharmaceuticals
Nov 18, 2015
CMO
Uninformative Sell
66.25K
$631.32
Aravive
Oct 23, 2017
―
Informative Sell
1.70K
$953.32
List of latest transactions for each holding click on a transaction to see Colin Hislop's performance on stock
You May Also Like
Colin Hislop insider profile FAQ
What is the percentage of profitable transactions made by Colin Hislop?
The percentage of profitable transactions made by Colin Hislop is 100%.
What is the average return per transaction made by Colin Hislop?
The average return per transaction made by Colin Hislop is 62.60%.
What stocks does Colin Hislop hold?
Colin Hislop holds: ANTH, ARAV stocks.
What was Colin Hislop’s latest transaction?
Colin Hislop latest transaction was an Informative Sell of $1.70K.
What was Colin Hislop's most profitable transaction?
Colin Hislop’s most profitable transaction was an Informative Sell of ARAV stock on October 23, 2017. The return on the trade was 63.00%.
What is Colin Hislop's role in Anthera Pharmaceuticals?
Colin Hislop's role in Anthera Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.